Mednarodni projekti
Open Multiscale Systems Medicine (OpenMultiMed)
Raziskovalci (2)
| št. |
Evidenčna št. |
Ime in priimek |
Razisk. področje |
Vloga |
Obdobje |
Štev. publikacijŠtev. publikacij |
| 1. |
18622 |
dr. Nataša Debeljak |
Biokemija in molekularna biologija |
Raziskovalec |
2016 - 2020 |
241 |
| 2. |
19104 |
dr. Blaž Stres |
Živalska produkcija in predelava |
Raziskovalec |
2016 - 2020 |
374 |
Organizacije (2)
Povzetek
Multiscale systems medicine assumes that the growing amounts of highly diverse (multiscale) data relevant to human health and disease are the key to address current and future medical challenges. Transforming these data into effective and economical medical solutions requires appropriate means for multiscale data modelling, integration and analysis. The overarching aim of the Open Multiscale Systems Medicine (OpenMultiMed) COST Action is to gather a critical mass of international researchers and coordinate them as a team that develops and evaluates a transdisciplinary framework for multiscale systems medicine, consisting of novel concepts, methodologies and technologies. The unique concept and ambition of the OpenMultiMed Action rests on three pillars: (1) A transdisciplinary strategy in which medical researchers, mathematical modellers, data scientist, and computer scientists work jointly using a shared conceptual framework and combined disciplinary-specific approaches. (2) A strong focus on multiscaleness across systems medicine, multiscale modelling, multiscale data science and multiscale computing. (3) An open-science approach, making scientific research, data and dissemination in multiscale systems medicine accessible to all levels of an inquiring European and international society. The potential impacts resulting from the OpenMultiMed Action include more effective and economical ways of health promotion, disease prevention and therapy; more effective and efficient concepts, methods and tools for multiscale systems and data modelling, and multiscale computing; and a strengthening of scientific excellence and industrial competitiveness of individuals and organizations in medical, analytical and technological areas.
